Stephen Salloway

Dr. Salloway is an internationally recognized leader in clinical trials for the prevention and treatment of Alzheimer’s disease. He received his MD from Stanford Medical School and completed residencies in neurology and psychiatry at Yale University. He is the founding Director of the Memory and Aging Program at Butler Hospital and Professor of Neurology and Psychiatry at the Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University. He has conducted more than 125 clinical trials to develop new diagnostic tests and treatments for Alzheimer’s disease, including serving as PI for the NE/RI site of the US POINTER study to promote brain health. He is a member of the steering committees for DIAN, ADNI, LEADS, ACTC and US POINTER. He is an expert on the clinical use of amyloid-lowering antibodies and he has been the lead author on landmark publications in the New England Journal of Medicine, Nature, Lancet and JAMA that have helped shaped the field of Alzh